Striking "seesaw effect" between daptomycin nonsusceptibility and β-lactam susceptibility in Staphylococcus haemolyticus

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 5, 2011, Pages 2495-2496

  Vignaroli, Carla ^a   Rinaldi, Caterina ^a   Varaldo, Pietro E ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM; DAPTOMYCIN; METICILLIN; PENICILLIN G; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; ENZYME SYNTHESIS; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPERON; PRIORITY JOURNAL; STAPHYLOCOCCUS HAEMOLYTICUS;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; DAPTOMYCIN; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS HAEMOLYTICUS;

EID: 79955533134     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00224-11     Document Type: Letter

References (9)

1. Bannerman, T. L., and S. J. Peacock. 2007. Staphylococcus, Micrococcus, and other catalase-positive cocci, p. 390-411. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. L. Landry, and M. A. Pfaller (ed.), Manual of clinical microbiology, 9th ed. ASM Press, Washington, DC.
2. Biavasco, F., C. Vignaroli, and P. E. Varaldo. 2000. Glycopeptide resistance in coagulase-negative staphylococci. Eur. J. Clin. Microbiol. Infect. Dis. 19:403-417.
3. Camargo, I. L., H. M. Neoh, L. Cui, and K. Hiramatsu. 2008. Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype. Antimicrob. Agents Chemother. 52:4289-4299.
4. Lee, C. H., M. C. Wang, I. W. Huang, F. J. Chen, and T. L. Lauderdale. 2010. Development of daptomycin nonsusceptibility with heterogeneous vancomycin- intermediate resistance and oxacillin susceptibility in methicillin-resistant Staphylococcus aureus during high-dose daptomycin treatment. Antimicrob. Agents Chemother. 54:4038-4040.
5. Mariani, P. G., H. S. Sader, and R. N. Jones. 2006. Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy. J. Antimicrob. Chemother. 58:481-483.
6. Mishra, N. N., et al. 2009. Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 53:2312-2318.
7. Sieradzki, K., and A. Tomasz. 1997. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus. J. Bacteriol. 179:2557-2566. (Pubitemid 27164554)
8. Vignaroli, C., F. Biavasco, and P. E. Varaldo. 2006. Interactions between glycopeptides and β-lactams against isogenic pairs of teicoplanin- susceptible and -resistant strains of Staphylococcus haemolyticus. Antimicrob. Agents Chemother. 50:2577-2582.
9. Yang, S. J., et al. 2010. Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect"). Antimicrob. Agents Chemother. 54:3161-3169.